콘텐츠로 건너뛰기
주식/증권 📈 긍정적

ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook

요약

Johnson & Johnson's Q2 beat and strong pharma momentum are raising interest in healthcare ETFs with sizable exposure to the company.